News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,926 Results
Type
Article (42537)
Company Profile (437)
Press Release (673952)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (209586)
Career Advice (2029)
Deals (36121)
Drug Delivery (106)
Drug Development (83699)
Employer Resources (174)
FDA (16485)
Job Trends (15278)
News (354018)
Policy (33149)
Tag
Academia (2650)
Accelerated approval (6)
Adcomms (25)
Allergies (88)
Alliances (51116)
ALS (94)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (140)
Approvals (16473)
Artificial intelligence (271)
Autoimmune disease (25)
Automation (16)
Bankruptcy (373)
Best Places to Work (11877)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (331)
Bladder cancer (83)
Brain cancer (27)
Breast cancer (287)
Cancer (2338)
Cardiovascular disease (191)
Career advice (1696)
Career pathing (30)
CAR-T (161)
Cell therapy (451)
Cervical cancer (19)
Clinical research (67865)
Collaboration (878)
Company closure (1)
Compensation (541)
Complete response letters (26)
COVID-19 (2653)
CRISPR (45)
C-suite (255)
Cystic fibrosis (107)
Data (2243)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (278)
Diagnostics (6454)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (128)
Drug pricing (110)
Drug shortages (26)
Duchenne muscular dystrophy (100)
Earnings (87950)
Editorial (41)
Employer branding (21)
Employer resources (148)
Events (116128)
Executive appointments (748)
FDA (17773)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (789)
Gene editing (113)
Generative AI (20)
Gene therapy (331)
GLP-1 (759)
Government (4521)
Grass and pollen (4)
Guidances (67)
Healthcare (19219)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (133)
Indications (30)
Infectious disease (2800)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (313)
IPO (16817)
IRA (43)
Job creations (3846)
Job search strategy (1441)
Kidney cancer (10)
Labor market (38)
Layoffs (501)
Leadership (18)
Legal (7996)
Liver cancer (76)
Lung cancer (332)
Lymphoma (158)
Machine learning (7)
Management (58)
Manufacturing (318)
MASH (71)
Medical device (13581)
Medtech (13586)
Mergers & acquisitions (19848)
Metabolic disorders (730)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2006)
NextGen: Class of 2025 (6797)
Non-profit (4562)
Now hiring (39)
Obesity (393)
Opinion (224)
Ovarian cancer (78)
Pain (92)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (21)
Patents (236)
Patient recruitment (114)
Peanut (47)
People (59020)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21332)
Phase II (29940)
Phase III (22146)
Pipeline (1231)
Policy (149)
Postmarket research (2602)
Preclinical (9149)
Press Release (68)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (264)
Rare diseases (407)
Real estate (6246)
Recruiting (67)
Regulatory (22801)
Reports (46)
Research institute (2424)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (141)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (30)
Startups (3781)
State (2)
Stomach cancer (15)
Supply chain (70)
Tariffs (41)
The Weekly (51)
Vaccines (714)
Venture capitalists (43)
Weight loss (261)
Women's health (37)
Worklife (17)
Date
Today (51)
Last 7 days (915)
Last 30 days (2653)
Last 365 days (33770)
2025 (11080)
2024 (36399)
2023 (41099)
2022 (52356)
2021 (56838)
2020 (55066)
2019 (47597)
2018 (35834)
2017 (33137)
2016 (32482)
2015 (38498)
2014 (32299)
2013 (27233)
2012 (29321)
2011 (29953)
2010 (28080)
Location
Africa (745)
Alabama (58)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (39446)
Australia (6563)
California (6284)
Canada (2034)
China (537)
Colorado (274)
Connecticut (288)
Delaware (151)
Europe (86391)
Florida (916)
Georgia (207)
Idaho (59)
Illinois (559)
India (25)
Indiana (313)
Iowa (12)
Japan (164)
Kansas (108)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (917)
Massachusetts (4763)
Michigan (222)
Minnesota (398)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1767)
New Mexico (30)
New York (1774)
North Carolina (1040)
North Dakota (8)
Northern California (2719)
Ohio (207)
Oklahoma (15)
Oregon (38)
Pennsylvania (1396)
Puerto Rico (12)
Rhode Island (34)
South America (1121)
South Carolina (23)
South Dakota (1)
Southern California (2345)
Tennessee (102)
Texas (931)
United States (23791)
Utah (184)
Virginia (151)
Washington D.C. (64)
Washington State (575)
West Virginia (3)
Wisconsin (55)
716,926 Results for "expansion therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics
May 1, 2025
·
2 min read
Press Releases
Vivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans
February 4, 2025
·
5 min read
Press Releases
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
April 30, 2025
·
6 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
May 1, 2025
·
9 min read
Press Releases
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
January 28, 2025
·
4 min read
FDA
J&J Wins Crohn’s Expansion for Tremfya as Stelara Biosimilars Enter US Market
The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar challenge.
March 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
March 20, 2025
·
8 min read
1 of 71,693
Next
